Microbot Medical shares surge 10.91% intraday as CEO presents LIBERTY system's clinical progress at Oppenheimer conference; system is FDA-cleared single-use robotic platform with planned full market launch in April 2026.

Microbot Medical surged 10.91% in intraday trading, driven by the company's first participation in the Oppenheimer healthcare conference and the FDA-cleared LIBERTY system's upcoming full-market release. The CEO will present clinical experiences and progress of the system, which is the only single-use remote-controlled robotic system, at the March 2026 conference, with a full-market launch planned for April 2026.